Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | FFR Technologies

August 18, 2020 — Philips Healthcare introduced its new OmniWire, the world’s first solid core fractional flow reserve ...

Home August 18, 2020
Home
News | Mobile C-Arms

August 18, 2020 — Ziehm Imaging announces the acquisition of Therenva, a French-based developer of planning and imaging ...

Home August 18, 2020
Home
News | Vascular Closure Devices

August 17, 2020 — Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure ...

Home August 17, 2020
Home
The Philips Healthcare Stellarex drug-coated balloon (DCB). It is cleared for use in peripheral vessels and treatment of failing AV access.
Feature | Drug-Eluting Balloons | Dave Fornell, Editor

Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high ...

Home August 06, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...

Home August 06, 2020
Home
Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for ...

Home August 05, 2020
Home
News | Cardiogenic Shock

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart ...

Home August 03, 2020
Home
Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 
Feature | Dave Fornell, Editor

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) mag ...

Home August 03, 2020
Home
News | Stents

July 24, 2020 — CeloNova BioSciences Inc. announced it successfully completed enrollment of the COBRA REDUCE randomized ...

Home July 24, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

July 22, 2020 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific's next generation Watchman ...

Home July 22, 2020
Home
News | Radiation Dose Management

July 21, 2020 — Interventional cardiology is ranked as the occupation with the highest level of radiation exposure in ...

Home July 21, 2020
Home
News | Atherectomy Devices

July 20, 2020 – BD (Becton, Dickinson and Company) recently completed the acquisition of Straub Medical AG, a privately ...

Home July 20, 2020
Home
Subscribe Now